The Global Hypertrophic and Keloid Scar Treatment Market Size accounted for USD 6.8 Billion in 2021 and is projected to achieve a market size of USD 15.7 Billion by 2030 rising at a CAGR of 10% from 2022 to 2030. The market is driven by rising consciousness about the aesthetic appearance. Scar treatment delivers complete skin rejuvenation, therefore improving aesthetic appeal. The need for aesthetic products mostly exists among women, which are the major consumers of these products. Also, the increase in the numeral of road accidents and burn cases has also influenced the development of the hypertrophic and keloid scar treatment market.
Hypertrophic and Keloid Scar Treatment Market Report Statistics
- Global hypertrophic & keloid scar treatment market revenue is estimated to reach USD 15.7 Billion by 2030 with a CAGR of 10% from 2022 to 2030
- North America hypertrophic and keloid scar treatment market share accounted for over 35% shares in 2021
- According to the Colorado Springs Dermatology Clinic, acne affects roughly 40 to 50 million people annually in the U.S.
- Asia-Pacific hypertrophic and keloid scar treatment market growth will register swift CAGR from 2022 to 2030
- Based on scar type, keloid captures over 65% of the overall market share in 2021
- Among end-user, hospitals occupied more than 44% of the market share from 2022 to 2030
- Growth in availability of technologically advanced products is a popular hypertrophic and keloid scar treatment market trend that is fueling the industry demand
Global Hypertrophic and Keloid Scar Treatment Market Dynamics
Market Drivers
- Growing demand for aesthetic surgeries
- Rising number of road accidents and burn cases
- Increasing advantages of laser treatment
- Surging need of topical solutions
Market Restraints
- High cost of these treatments
- Lack of awareness among developing countries
Market Opportunities
- Increasing healthcare expenditure
- Growth in research & development activities
Hypertrophic and Keloid Scar Treatment Market Report Coverage
| Market |
Hypertrophic and Keloid Scar Treatment Market |
| Hypertrophic and Keloid Scar Treatment Market Size 2021 |
USD 6.8 Billion |
| Hypertrophic and Keloid Scar Treatment Market Forecast 2030 |
USD 15.7 Billion |
| Hypertrophic and Keloid Scar Treatment Market CAGR During 2022 - 2030 |
10% |
| Hypertrophic and Keloid Scar Treatment Market Analysis Period |
2018 - 2030 |
| Hypertrophic and Keloid Scar Treatment Market Base Year |
2021 |
| Hypertrophic and Keloid Scar Treatment Market Forecast Data |
2022 - 2030 |
| Segments Covered |
By Scar Type, By Product, By End-User, And By Geography
|
| Regional Scope |
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa |
| Key Companies Profiled |
Sonoma Pharmaceuticals, Inc., Lumenis Ltd., Suneva Medical, Inc., Alliance Pharma, PLC, Smith & Nephew PLC, Merz Pharmaceuticals, LLC, Mölnlycke Health Care AB, Newmedical Technology, Inc., Cynosure, Inc., Perrigo Company PLC, and Enaltus, LLC. |
Report Coverage
|
Market Trends, Drivers, Restraints, Competitive Analysis, Player Profiling, Regulation Analysis |
Hypertrophic and Keloid Scar Treatment Market Growth Factors
Increase in consciousness regarding esthetic appeal has led to the market development. As per Plastic Surgery Statistics Report, around 182,321 reconstructive processes for scar revision were performed in 2017. Henceforth, the need for reconstructive processes also plays a significant role in boost up the market development.
Hypertrophic and Keloid Scar Treatment Market Insights
Increase in burn injury cases has also led to augmented need for hypertrophic and keloid scar treatments. Plastic surgeries or resurfacing laser therapies are usually performed to eliminate these marks. Hypertrophic burn marks can affect a victim’s appearance and are related with other conditions, for instance, contractures and pruritis.
The introduction of technically advanced products, for instance, laser therapies, will also support industry growth. These products assistance reduce scars caused owing to trauma injuries, burns, and surgery. For example, Non-ablative laser therapy destroys scar tissues through vascularization with the aid of a pulsed dye laser. Though, exorbitant prices of laser products are expected to hamper the market development.
Hypertrophic and Keloid Scar Treatment Market Segmentation
The global hypertrophic and keloid scar treatment market is segmented based on scar type, product, end-user, and geography.
Hypertrophic and Keloid Scar Treatment Market By Scar Type
According to the hypertrophic and keloid scar treatment industry analysis, keloid sub-segment generated the largest revenue in 2021 and is expected to do so in the coming years. Keloid scars can grow large and extend beyond the wound area. Furthermore, these scars are more difficult to heal and have a high recurrence rate. In addition to that, hypertrophic sub-segment is expected to attain a significant growth rate during the projected timeframe.
Hypertrophic and Keloid Scar Treatment Market By Product
- Topical Products
- Silicone Sheets
- Creams
- Gels
- Others
- Laser Product
- Injectable
- Others
As per hypertrophic and keloid scar treatment market forecast, the topical products sub-segment accounted for 41% market shares in 2021 and is expected to maintain this trend over the forecasted timeframe of 2022 to 2030. This dominance can be linked to the increased use of topical products on hypertrophic and keloid scars, such as lotions, silicone sheets, and gels. Because these topical medicines are easily accessible to clients as over-the-counter (OTC) items, they are often purchased.
Hypertrophic and Keloid Scar Treatment Market By End-User
- Hospitals
- Clinics
- Retail Pharmacies/E-commerce
Based on end-user, the hospitals segment will lead the market in 2021, controlling for more than 44% of total revenue. This can be attributed to an increase in hospital admissions as well as an increase in the number of hospitals worldwide. The retail pharmacies/e-commerce segment is expected to grow at the fastest rate over the forecast period. This can be credited to the nature of product availability.
Hypertrophic and Keloid Scar Treatment Market Regional Outlook
North America
Europe
- U.K.
- Germany
- France
- Spain
- Rest of Europe
Asia-Pacific
- India
- Japan
- China
- Australia
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Mexico
- Rest of Latin America
The Middle East & Africa
- South Africa
- GCC Countries
- Rest of the Middle East & Africa (ME&A)
Hypertrophic and Keloid Scar Treatment Market Regional Analysis
In 2021, North America captures the largest market share and is expected to observer steady growth during the forthcoming years. High prevalence of skin-related disorders, burn injuries, and trauma are among the main factors accountable for the market growth. Furthermore, accessibility and acceptance of progressive treatment options, for instance, laser treatments, are projected to support the development. Asia-Pacific is expected to observer the fastest CAGR over the forecast time frame due to obtainability of technically progressive products and occurrence of a large numeral of producers in nations, for instance, China. Accessibility of laser instruments at cheaper prices in developing countries has increased their acceptance, thus pushing market growth. Due to high incidence of burn injuries, India has also backed considerably to the region’s development.
Hypertrophic and Keloid Scar Treatment Market Players
Market companies are concentrating on implementing new strategies for instance regional expansion, partnerships, mergers and acquisitions, new product launches, and distribution agreements to surge their revenue share. The major players associated with the Hypertrophic & keloid scar treatment market are Sonoma Pharmaceuticals, Inc., Lumenis Ltd., Suneva Medical, Inc., Alliance Pharma, PLC, Smith & Nephew PLC, Merz Pharmaceuticals, LLC, Mölnlycke Health Care AB, Newmedical Technology, Inc., Cynosure, Inc., Perrigo Company PLC, and Enaltus, LLC.
CHAPTER 1. Industry Overview of Hypertrophic and Keloid Scar Treatment Market
1.1. Definition and Scope
1.1.1. Definition of Hypertrophic and Keloid Scar Treatment
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Hypertrophic and Keloid Scar Treatment Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Hypertrophic and Keloid Scar Treatment Market By Scar Type
1.2.3. Hypertrophic and Keloid Scar Treatment Market By Product
1.2.4. Hypertrophic and Keloid Scar Treatment Market By End-User
1.2.5. Hypertrophic and Keloid Scar Treatment Market By Region
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Sources
2.2.2. Primary Sources
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restraint 1
3.2.2. Restraint 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Hypertrophic and Keloid Scar Treatment Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Hypertrophic and Keloid Scar Treatment Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Regulatory Compliance
3.9. Competitive Landscape, 2021
3.9.1. Player Positioning Analysis
3.9.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Hypertrophic and Keloid Scar Treatment Market By Scar Type
4.1. Introduction
4.2. Hypertrophic and Keloid Scar Treatment Revenue By Product
4.2.1. Hypertrophic and Keloid Scar Treatment Revenue (USD Billion) and Forecast, By Product, 2018-2030
4.2.2. Hypertrophic
4.2.2.1. Hypertrophic Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
4.2.3. Keloid
4.2.3.1. Keloid Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
CHAPTER 5. Hypertrophic and Keloid Scar Treatment Market By Product
5.1. Introduction
5.2. Hypertrophic and Keloid Scar Treatment Revenue By Product
5.2.1. Hypertrophic and Keloid Scar Treatment Revenue (USD Billion) and Forecast, By Product, 2018-2030
5.2.2. Topical Products
5.2.2.1. Topical Products Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
5.2.2.2. Silicone Sheets
5.2.2.2.1. Silicone Sheets Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
5.2.2.3. Creams
5.2.2.3.1. Creams Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
5.2.2.4. Gels
5.2.2.4.1. Gels Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
5.2.2.5. Others
5.2.2.5.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
5.2.3. Laser Products
5.2.3.1. Laser Products Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
5.2.3.2. Pulse-Dyed
5.2.3.2.1. Pulse-Dyed Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
5.2.3.3. CO2
5.2.3.3.1. CO2 Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
5.2.3.4. Others
5.2.3.4.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
5.2.4. Injectable
5.2.4.1. Injectable Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
5.2.5. Others
5.2.5.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
CHAPTER 6. Hypertrophic and Keloid Scar Treatment Market By End-User
6.1. Introduction
6.2. Hypertrophic and Keloid Scar Treatment Revenue By End-User
6.2.1. Hypertrophic and Keloid Scar Treatment Revenue (USD Billion) and Forecast, By End-User, 2018-2030
6.2.2. Hospitals
6.2.2.1. Hospitals Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
6.2.3. Clinics
6.2.3.1. Clinics Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
6.2.4. Retail Pharmacies/E-commerce
6.2.4.1. Retail Pharmacies/E-commerce Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
CHAPTER 7. North America Hypertrophic and Keloid Scar Treatment Market By Country
7.1. North America Hypertrophic and Keloid Scar Treatment Market Overview
7.2. U.S.
7.2.1. U.S. Hypertrophic and Keloid Scar Treatment Revenue (USD Billion) and Forecast By Scar Type, 2018-2030
7.2.2. U.S. Hypertrophic and Keloid Scar Treatment Revenue (USD Billion) and Forecast By Product, 2018-2030
7.2.3. U.S. Hypertrophic and Keloid Scar Treatment Revenue (USD Billion) and Forecast By End-User, 2018-2030
7.3. Canada
7.3.1. Canada Hypertrophic and Keloid Scar Treatment Revenue (USD Billion) and Forecast By Scar Type, 2018-2030
7.3.2. Canada Hypertrophic and Keloid Scar Treatment Revenue (USD Billion) and Forecast By Product, 2018-2030
7.3.3. Canada Hypertrophic and Keloid Scar Treatment Revenue (USD Billion) and Forecast By End-User, 2018-2030
7.4. North America PEST Analysis
CHAPTER 8. Europe Hypertrophic and Keloid Scar Treatment Market By Country
8.1. Europe Hypertrophic and Keloid Scar Treatment Market Overview
8.2. U.K.
8.2.1. U.K. Hypertrophic and Keloid Scar Treatment Revenue (USD Billion) and Forecast By Scar Type, 2018-2030
8.2.2. U.K. Hypertrophic and Keloid Scar Treatment Revenue (USD Billion) and Forecast By Product, 2018-2030
8.2.3. U.K. Hypertrophic and Keloid Scar Treatment Revenue (USD Billion) and Forecast By End-User, 2018-2030
8.3. Germany
8.3.1. Germany Hypertrophic and Keloid Scar Treatment Revenue (USD Billion) and Forecast By Scar Type, 2018-2030
8.3.2. Germany Hypertrophic and Keloid Scar Treatment Revenue (USD Billion) and Forecast By Product, 2018-2030
8.3.3. Germany Hypertrophic and Keloid Scar Treatment Revenue (USD Billion) and Forecast By End-User, 2018-2030
8.4. France
8.4.1. France Hypertrophic and Keloid Scar Treatment Revenue (USD Billion) and Forecast By Scar Type, 2018-2030
8.4.2. France Hypertrophic and Keloid Scar Treatment Revenue (USD Billion) and Forecast By Product, 2018-2030
8.4.3. France Hypertrophic and Keloid Scar Treatment Revenue (USD Billion) and Forecast By End-User, 2018-2030
8.5. Spain
8.5.1. Spain Hypertrophic and Keloid Scar Treatment Revenue (USD Billion) and Forecast By Scar Type, 2018-2030
8.5.2. Spain Hypertrophic and Keloid Scar Treatment Revenue (USD Billion) and Forecast By Product, 2018-2030
8.5.3. Spain Hypertrophic and Keloid Scar Treatment Revenue (USD Billion) and Forecast By End-User, 2018-2030
8.6. Rest of Europe
8.6.1. Rest of Europe Hypertrophic and Keloid Scar Treatment Revenue (USD Billion) and Forecast By Scar Type, 2018-2030
8.6.2. Rest of Europe Hypertrophic and Keloid Scar Treatment Revenue (USD Billion) and Forecast By Product, 2018-2030
8.6.3. Rest of Europe Hypertrophic and Keloid Scar Treatment Revenue (USD Billion) and Forecast By End-User, 2018-2030
8.7. Europe PEST Analysis
CHAPTER 9. Asia Pacific Hypertrophic and Keloid Scar Treatment Market By Country
9.1. Asia Pacific Hypertrophic and Keloid Scar Treatment Market Overview
9.2. China
9.2.1. China Hypertrophic and Keloid Scar Treatment Revenue (USD Billion) and Forecast By Scar Type, 2018-2030
9.2.2. China Hypertrophic and Keloid Scar Treatment Revenue (USD Billion) and Forecast By Product, 2018-2030
9.2.3. China Hypertrophic and Keloid Scar Treatment Revenue (USD Billion) and Forecast By End-User, 2018-2030
9.3. Japan
9.3.1. Japan Hypertrophic and Keloid Scar Treatment Revenue (USD Billion) and Forecast By Scar Type, 2018-2030
9.3.2. Japan Hypertrophic and Keloid Scar Treatment Revenue (USD Billion) and Forecast By Product, 2018-2030
9.3.3. Japan Hypertrophic and Keloid Scar Treatment Revenue (USD Billion) and Forecast By End-User, 2018-2030
9.4. India
9.4.1. India Hypertrophic and Keloid Scar Treatment Revenue (USD Billion) and Forecast By Scar Type, 2018-2030
9.4.2. India Hypertrophic and Keloid Scar Treatment Revenue (USD Billion) and Forecast By Product, 2018-2030
9.4.3. India Hypertrophic and Keloid Scar Treatment Revenue (USD Billion) and Forecast By End-User, 2018-2030
9.5. Australia
9.5.1. Australia Hypertrophic and Keloid Scar Treatment Revenue (USD Billion) and Forecast By Scar Type, 2018-2030
9.5.2. Australia Hypertrophic and Keloid Scar Treatment Revenue (USD Billion) and Forecast By Product, 2018-2030
9.5.3. Australia Hypertrophic and Keloid Scar Treatment Revenue (USD Billion) and Forecast By End-User, 2018-2030
9.6. South Korea
9.6.1. South Korea Hypertrophic and Keloid Scar Treatment Revenue (USD Billion) and Forecast By Scar Type, 2018-2030
9.6.2. South Korea Hypertrophic and Keloid Scar Treatment Revenue (USD Billion) and Forecast By Product, 2018-2030
9.6.3. South Korea Hypertrophic and Keloid Scar Treatment Revenue (USD Billion) and Forecast By End-User, 2018-2030
9.7. Rest of Asia-Pacific
9.7.1. Rest of Asia-Pacific Hypertrophic and Keloid Scar Treatment Revenue (USD Billion) and Forecast By Scar Type, 2018-2030
9.7.2. Rest of Asia-Pacific Hypertrophic and Keloid Scar Treatment Revenue (USD Billion) and Forecast By Product, 2018-2030
9.7.3. Rest of Asia-Pacific Hypertrophic and Keloid Scar Treatment Revenue (USD Billion) and Forecast By End-User, 2018-2030
9.8. Asia Pacific PEST Analysis
CHAPTER 10. Latin America Hypertrophic and Keloid Scar Treatment Market By Country
10.1. Latin America Hypertrophic and Keloid Scar Treatment Market Overview
10.2. Brazil
10.2.1. Brazil Hypertrophic and Keloid Scar Treatment Revenue (USD Billion) and Forecast By Scar Type, 2018-2030
10.2.2. Brazil Hypertrophic and Keloid Scar Treatment Revenue (USD Billion) and Forecast By Product, 2018-2030
10.2.3. Brazil Hypertrophic and Keloid Scar Treatment Revenue (USD Billion) and Forecast By End-User, 2018-2030
10.3. Mexico
10.3.1. Mexico Hypertrophic and Keloid Scar Treatment Revenue (USD Billion) and Forecast By Scar Type, 2018-2030
10.3.2. Mexico Hypertrophic and Keloid Scar Treatment Revenue (USD Billion) and Forecast By Product, 2018-2030
10.3.3. Mexico Hypertrophic and Keloid Scar Treatment Revenue (USD Billion) and Forecast By End-User, 2018-2030
10.4. Rest of Latin America
10.4.1. Rest of Latin America Hypertrophic and Keloid Scar Treatment Revenue (USD Billion) and Forecast By Scar Type, 2018-2030
10.4.2. Rest of Latin America Hypertrophic and Keloid Scar Treatment Revenue (USD Billion) and Forecast By Product, 2018-2030
10.4.3. Rest of Latin America Hypertrophic and Keloid Scar Treatment Revenue (USD Billion) and Forecast By End-User, 2018-2030
10.5. Latin America PEST Analysis
CHAPTER 11. Middle East & Africa Hypertrophic and Keloid Scar Treatment Market By Country
11.1. Middle East & Africa Hypertrophic and Keloid Scar Treatment Market Overview
11.2. GCC
11.2.1. GCC Hypertrophic and Keloid Scar Treatment Revenue (USD Billion) and Forecast By Scar Type, 2018-2030
11.2.2. GCC Hypertrophic and Keloid Scar Treatment Revenue (USD Billion) and Forecast By Product, 2018-2030
11.2.3. GCC Hypertrophic and Keloid Scar Treatment Revenue (USD Billion) and Forecast By End-User, 2018-2030
11.3. South Africa
11.3.1. South Africa Hypertrophic and Keloid Scar Treatment Revenue (USD Billion) and Forecast By Scar Type, 2018-2030
11.3.2. South Africa Hypertrophic and Keloid Scar Treatment Revenue (USD Billion) and Forecast By Product, 2018-2030
11.3.3. South Africa Hypertrophic and Keloid Scar Treatment Revenue (USD Billion) and Forecast By End-User, 2018-2030
11.4. Rest of Middle East & Africa
11.4.1. Rest of Middle East & Africa Hypertrophic and Keloid Scar Treatment Revenue (USD Billion) and Forecast By Scar Type, 2018-2030
11.4.2. Rest of Middle East & Africa Hypertrophic and Keloid Scar Treatment Revenue (USD Billion) and Forecast By Product, 2018-2030
11.4.3. Rest of Middle East & Africa Hypertrophic and Keloid Scar Treatment Revenue (USD Billion) and Forecast By End-User, 2018-2030
11.5. Middle East & Africa PEST Analysis
CHAPTER 12. Player Analysis Of Hypertrophic and Keloid Scar Treatment Market
12.1. Hypertrophic and Keloid Scar Treatment Market Company Share Analysis
12.2. Competition Matrix
12.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment
12.2.2. New Product Launches and Product Enhancements
12.2.3. Mergers And Acquisition In Global Hypertrophic and Keloid Scar Treatment Market
12.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 13. Company Profile
13.1. Sonoma Pharmaceuticals, Inc.
13.1.1. Company Snapshot
13.1.2. Business Overview
13.1.3. Financial Overview
13.1.3.1. Revenue (USD Billion), 2021
13.1.3.2. Sonoma Pharmaceuticals, Inc. 2021 Hypertrophic and Keloid Scar Treatment Business Regional Distribution
13.1.4. Product /Service and Specification
13.1.5. Recent Developments & Business Strategy
13.2. Lumenis Ltd.
13.3. Suneva Medical, Inc.
13.4. Alliance Pharma, PLC
13.5. Smith & Nephew PLC
13.6. Merz Pharmaceuticals, LLC
13.7. Mölnlycke Health Care AB
13.8. Newmedical Technology, Inc.
13.9. Cynosure, Inc.
13.10. Perrigo Company PLC
13.11. Enaltus, LLC
